Product Information
BUPRENORPHINE 7.5 MCG/HR PATCH is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $37.8502 per EA under NDC 42858035340. Its NADAC has been published 383 times since Jul 18, 2018.
FDA first approved this application on Jun 30, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 ug/h
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858035340
Classification
Generic
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021306FDA Approved
6/30/2010
TE Code
AB
On Market Since
7/3/2017
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has been published 383 times since Jul 18, 2018, and over the history we have for it it has declined 42.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $37.8502 per EA |
|---|---|
| All-time high | $72.3075 (Dec 11, 2019) |
| All-time low | $25.3493 (Nov 20, 2024) |
| 52-week high | $37.8502 |
| 52-week low | $30.1197 |
| Median price | $49.9668 |
| Average price | $50.6714 |
| Largest weekly change | +34.4% (Dec 21, 2022) |
| Weeks tracked | 383 |
| Tracking since | Jul 18, 2018 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE 7.5 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE 7.5 MCG/HR PATCH, manufactured by Rhodes Pharmaceuticals L.P., is $37.8502 per EA (NDC 42858035340), effective Aug 19, 2026.
How has the price of BUPRENORPHINE 7.5 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has declined 42.9%. It has been tracked across 383 weekly CMS publications since Jul 18, 2018.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE 7.5 MCG/HR PATCH?
Since Jul 18, 2018, the NADAC for BUPRENORPHINE 7.5 MCG/HR PATCH has ranged from a low of $25.3493 (Nov 20, 2024) to a high of $72.3075 (Dec 11, 2019), with a median of $49.9668 per EA.
Are there cheaper alternatives to BUPRENORPHINE 7.5 MCG/HR PATCH?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE 7.5 MCG/HR PATCH in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE 7.5 MCG/HR PATCH?
BUPRENORPHINE 7.5 MCG/HR PATCH (NDC 42858035340) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.